-0.03 (-1.0%)
ASX:Live
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Weak
Halo Model
MQV
Strong
GARP
Neutral
MQV Small
Neutral
Valuation
Value
Consensus
Momentum
Price
Very Strong
Earnings
Neutral
Growth
Earnings
Neutral
Dividends
Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Weak
Website
N/A
Telephone
61.13.0045.3688
Address
1868-1892 Dandenong Road Clayton, Victoria (VIC) 3168
Description
Australian Clinical Labs Ltd. engages in the provision of pathology services. It operates through the Pathology segment. The Pathology segment includes pathology/clinical laboratory services provided in Australia. The company was founded in 2015 and is headquartered in Clayton, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 2.14 - 3.86
Trade Value (12mth)
AU$948,598.00
1 week
-0.99%
1 month
-3.23%
YTD
-12.28%
1 year
11.52%
All time high
6.39
EPS 3 yr Growth
-69.70%
EBITDA Margin
26.90%
Operating Cashflow
$160m
Free Cash Flow Return
41.50%
ROIC
6.20%
Interest Coverage
10.90
Quick Ratio
0.60
Shares on Issue (Fully Dilluted)
202m
HALO Sector
Healthcare
Next Company Report Date
20-Aug-25
Ex Dividend Date (est.)
27-Mar-25
Next Dividend Pay Date (est.)
16-Apr-25
Reporting Currency
AUD
Short Sell (% of issue)
2.19
| Date | Announcements |
|---|---|
|
26 March 25 |
Notification of cessation of securities - ACL
×
Notification of cessation of securities - ACL |
|
25 March 25 |
Change in substantial holding from CBA
×
Change in substantial holding from CBA |
|
24 March 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
21 March 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
13 March 25 |
Becoming a substantial holder
×
Becoming a substantial holder |
|
13 March 25 |
Notification of cessation of securities - ACL
×
Notification of cessation of securities - ACL |
|
12 March 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
11 March 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
11 March 25 |
Ceasing to be a substantial holder from MUFG
×
Ceasing to be a substantial holder from MUFG |
|
10 March 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
10 March 25 |
Notification of cessation of securities - ACL
×
Notification of cessation of securities - ACL |
|
10 March 25 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
|
03 March 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
03 March 25 |
Notification regarding unquoted securities - ACL
×
Notification regarding unquoted securities - ACL |
|
03 March 25 |
Notification regarding unquoted securities - ACL
×
Notification regarding unquoted securities - ACL |
|
03 March 25 |
Becoming a substantial holder from WMI/WAM/WAX
×
Becoming a substantial holder from WMI/WAM/WAX |
|
28 February 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
28 February 25 |
Response to ASX Aware Letter
×
Response to ASX Aware Letter |
|
27 February 25 |
Update - Notification of buy-back - ACL
×
Update - Notification of buy-back - ACL |
|
26 February 25 |
Appendix 4D and 1H25 financial statements
×
Appendix 4D and 1H25 financial statements |
|
26 February 25 |
1H25 financial results investor presentation
×
1H25 financial results investor presentation |
|
26 February 25 |
Dividend/Distribution - ACL
×
Dividend/Distribution - ACL |
|
17 February 25 |
1H25 financial results - investor webinar
×
1H25 financial results - investor webinar |
|
04 February 25 |
Change in substantial holding
×
Change in substantial holding |
|
04 February 25 |
Initial Director's Interest Notice - G Jeffery
×
Initial Director's Interest Notice - G Jeffery |
Load More
Load Less
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
.svg)
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.
